uOmnispace.CT

uOmnispace.CT is a comprehensive medical image processing software providing a suite of tools for detailed analysis and quantitative evaluation of CT scans across various anatomical systems, aiming to enhance diagnostic accuracy. Its methodology integrates diverse computational techniques, including advanced segmentation, parameter calculation for functional assessments, and AI/deep learning algorithms for tasks like anatomical labeling and procedural planning, particularly evident in its bone structure and TAVR analysis modules.

uOmnispace.CT is an advanced medical image post-processing software suite designed for comprehensive viewing, manipulation, evaluation, and analysis of Computed Tomography (CT) images. It operates on the uOmnispace platform, providing clinicians with a versatile tool to support the interpretation and evaluation of examinations across a wide range of healthcare institutions. The system's core purpose is to enhance diagnostic capabilities by offering specialized applications that improve visualization and deliver quantitative data for various anatomical regions and clinical tasks. The software features a diverse array of applications, including Colon Analysis for CT colonography, a Dental module for panoramic and paraxial jaw reconstructions, and dedicated tools for Lung Density and Nodule analysis. It also offers Vessel Analysis, Brain Perfusion (calculating parameters like CBV, CBF, Tmax, and ischemic penumbra), Heart analysis (segmentation, stenosis, plaque, function), Calcium Scoring (with comparison to the MESA database), and Bone Structure Analysis, which utilizes deep learning for automated rib and spine labeling. Further functionalities include Liver Evaluation (segmentation, vessel extraction, territories computation), Dual Energy CT analysis for material decomposition and multi-energy image generation, and a Cardiovascular Combined Analysis module for integrated cardiac/vascular assessment and Transcatheter Aortic Valve Replacement (TAVR) planning, which also employs AI-driven algorithms. Performance verification for its AI/ML-based algorithms demonstrated high accuracy and generalization across varied datasets and demographic subgroups.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. What are the specific deep learning model architectures and training dataset characteristics used for the spine and rib labeling algorithms, and how do they compare to other state-of-the-art segmentation methods?; For the TAVR analysis algorithm, what were the primary challenges in achieving the <1mm mean landmark error, and what measures ensure its robustness across varied patient anatomies and image qualities?; How does the uOmnispace.CT Dual Energy application's chemical composition analysis (e.g., for kidney stones, gout) quantitatively compare in accuracy and reproducibility to established physical or ex-vivo analysis methods?; Regarding the Brain Perfusion module, what are the validation details for Tmax and ischemic penumbra analysis against the reference device (iSchema View's RAPID), particularly concerning different stroke etiologies or scanner protocols?; Can the uOmnispace.CT platform integrate or process images from CT scanner manufacturers not explicitly listed in the ML/AI performance testing (GE, Phillips, Siemens, Toshiba, UIH) with comparable accuracy for its advanced analysis modules?